Literature DB >> 15013613

A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup.

Feyzullah Cetinkaya1, Bilge Sertel Tüfekçi, Günsel Kutluk.   

Abstract

OBJECTIVES: Croup or acute laryngotracheobronchitis is the most common cause of the upper airway obstruction. Cool mist, nebulized racemic epinephrine and steroids are commonly used for therapy. Although steroid treatment can be applied orally, in nebulized form, or parenterally, no study has compared these three regimens yet. In this study, the efficacy of nebulized budesonide, and oral and intramuscular dexamethasone are compared for treatment of croup. STUDY
DESIGN: Sixty children aged 6-36 months were randomly allocated into four groups. The first three study groups (15 children in each) took nebulized budesonide, oral dexamethasone and intramuscular dexamethasone, respectively, in addition to salbutamol and other supportive measures and these were compared with the placebo group. All patients were evaluated with "Westley Croup Score" on admission to pediatric emergency department (0h) and at 24, 48 and 72h.
RESULTS: At the end of the study, the croup scores of all steroid treatment groups were significantly lower than the placebo group, but there was no statistical difference among them.
CONCLUSIONS: Nebulized budesonide, oral and parenteral dexamethasone have the same effectiveness for treatment of croup and the choice depends on conditions of the patient and the physician.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013613     DOI: 10.1016/j.ijporl.2003.11.017

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  7 in total

1.  Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose.

Authors:  Piotr Dobrowolski; Ewa Tomaszewska; Siemowit Muszyński; Tomasz Blicharski; Stefan G Pierzynowski
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

2.  Croup in the paediatric emergency department.

Authors:  Candice L Bjornson; David W Johnson
Journal:  Paediatr Child Health       Date:  2007-07       Impact factor: 2.253

3.  Scientific rationale for the use of alpha-adrenergic agonists and glucocorticoids in the therapy of pediatric stridor.

Authors:  Gustavo Nino; Orkun Baloglu; Maria J Gutierrez; Michael Schwartz
Journal:  Int J Otolaryngol       Date:  2011-12-19

4.  Glucocorticoids for croup in children.

Authors:  Allison Gates; Michelle Gates; Ben Vandermeer; Cydney Johnson; Lisa Hartling; David W Johnson; Terry P Klassen
Journal:  Cochrane Database Syst Rev       Date:  2018-08-22

Review 5.  Upper respiratory infections.

Authors:  Samuel N Grief
Journal:  Prim Care       Date:  2013-07-12       Impact factor: 2.907

Review 6.  Common pediatric respiratory emergencies.

Authors:  Joseph Choi; Gary L Lee
Journal:  Emerg Med Clin North Am       Date:  2011-12-17       Impact factor: 2.264

Review 7.  Croup.

Authors:  Candice L Bjornson; David W Johnson
Journal:  Lancet       Date:  2008-01-26       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.